Does the FDA approve long-term HRT use

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

According to FDA.gov, the FDA does not set a specific time limit for how long a woman may use hormone therapy. According to the FDA-approved prescribing information for estrogen and estrogen-progestin products, HRT is indicated for menopausal symptoms and requires use at the lowest effective dose for the shortest duration that meets a woman's treatment goals. The FDA also recognizes that for some women, this may mean many years of treatment if benefits continue to outweigh risks, as assessed by a qualified prescriber.

Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

What the FDA Actually Approves

According to FDA.gov, the FDA approves estrogen and estrogen-progestin therapies for treating hot flashes, night sweats, vaginal dryness, and prevention of bone loss. According to the FDA-approved prescribing information for these products, approvals do not include a fixed maximum duration. Instead, the FDA places responsibility on the clinician and patient to review benefits and risks annually and continue only if therapy remains clearly beneficial, as determined by a qualified prescriber.

What "Lowest Effective Dose for the Shortest Duration" Means

• Lowest effective dose: The smallest amount of hormone that may control symptoms or support bone health, as determined by a qualified prescriber.
• Shortest duration: Not a set number of years. It means "no longer than needed." For some, this is 2 to 5 years; for others, it may be 10 to 15 years or more, based on individual clinical reassessment.
• Annual reassessment: According to FDA-approved prescribing information, a qualified prescriber should periodically review symptoms, risks, family history, blood pressure, and the patient's overall benefit-risk profile.

Is Long-Term Use Allowed?

According to FDA.gov, the FDA does allow long-term use when a woman continues to benefit and has no new risk factors that make HRT inadvisable for her. According to NAMS and ACOG, many professional societies support individualized, ongoing reassessment for women who continue to derive benefit from hormone therapy.

Why the FDA Avoids Setting a Maximum Duration

• Women's risks differ widely; age alone does not determine safety for any individual.
• Symptoms may persist well beyond the traditional 5-year window.
• Modern lower-dose and transdermal options may carry different risk profiles, as noted in their respective FDA-approved prescribing information.

According to FDA.gov, long-term HRT may be appropriate when thoughtfully chosen, regularly reviewed by a qualified prescriber, and genuinely improving a woman's quality of life.